Age, sex, and secondary prevention of ischaemic heart disease in everyday practice

Kardiologia Polska

Volumn 71, Issue 12, 2013, Pages 1251-1259

  Jankowski, Piotr ^a   Czarnecka, Danuta ^a   Wolfshaut Wolak, Renata ^a   Łysek, Radosław ^a   Łukaszewska, Anna ^a   Surowiec, Sławomir ^a   Loster, Magdalena ^a   Bogacki, Piotr ^b   Bryniarska Mirek, Ewa ^c   Grodecki, Janusz ^d   Nessler, Jadwiga ^a   Podolec, Piotr ^a   Kawecka Jaszcz, Kalina ^a   Paja̧k, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Ludwik Rydygier District Hospital   (Poland)

^c Jozef Dietl Hospital   (Poland)

^d Department of Cardiology   (Poland)

Author keywords

Age; Coronary artery disease; Risk factors; Secondary prevention; Sex

Indexed keywords

CALCIUM ANTAGONIST; DIURETIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLAND; PRESCRIPTION; SECONDARY PREVENTION; SEX DIFFERENCE; UNSTABLE ANGINA PECTORIS;

AGE FACTORS; AGED; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PHYSICIAN'S PRACTICE PATTERNS; POLAND; RETROSPECTIVE STUDIES; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; SMOKING;

EID: 84890475238     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.a2013.0148     Document Type: Article

References (43)

1. Fifth Joint Task Force of the European Society of Cardiology. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Prev Cardiol, 2012; 19: 585-667.
2. Anand SS, Xie CC, Mehta S et al. Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. J Am Coll Cardiol, 2005; 46: 1845-1851.
3. Velders MA, Boden H, van Boven AJ et al. Influence of Gender on Ischemic Times and Outcomes After ST-Elevation Myocardial Infarction. Am J Cardiol, 2013; 111: 312-318.
4. Janion M, Polewczyk A, Sielski J et al. Odmienności przebiegu choroby niedokrwiennej serca u kobiet. Kardiol Pol, 2006; 64: 628-636.
5. Roeters van Lennep JE, Zwinderman AH et al. Gender differences in diagnosis and treatment of coronary artery disease from 1981 to 1997. No evidence for the Yentl syndrome. Eur Heart J, 2000; 21: 911-918.
6. Sadowski M, Ga̧sior M, Gierlotka M et al. Gender-related differences in mortality after ST-segment elevation myocardial infarction: a large multicentre national registry. EuroIntervention, 2011; 6: 1068-1072.
7. Nauta ST, Deckers JW, van Domburg RT et al. Sex-related trends in mortality in hospitalized men and women after myocardial infarction between 1985 and 2008: equal benefit for women and men. Circulation, 2012; 126: 2184-2189.
8. Daly CA, De Stavola B, Sendon JL et al. Predicting prognosis instable angina: results from the Euro heart survey of stable angina: prospective observational study. BMJ, 2006; 32: 262-267.
9. Daly C, Klemens F, Sendon JL et al. Gender differences in the management and clinical outcome of stable angina. Circulation, 2006; 113: 490-498.
10. Jankowski P, Kawecka-Jaszcz K, Czarnecka D et al. Gender does not influence event-free survival in patients with ischaemic heart disease undergoing non-emergency coronary angiography. A single centre analysis. Kardiol Pol, 2007; 65: 475-484.
11. Lahoz C, Mantilla T, Taboada M et al. Gender differences in evidence-based pharmacological therapy for patients with stable coronary heart disease. Int J Cardiol, 2009; 133: 336-340.
12. Dallongevillle J, De Bacquer D, Heidrich J et al. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart, 2010; 96: 1744-1749.
13. Schmidt M, Jacobsen JB, Lash TL et al. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ, 2012; 344: e356.
14. Steg PG, Greenlaw N, Tardif JC et al. Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J, 2012; 33: 2831-2840.
15. Gierlotka M, Ga̧sior M, Wilczek K et al. Temporal Trends in the Treatment and Outcomes of Patients With Non-ST-Segment Elevation Myocardial Infarction in Poland from 2004-2010 (from the Polish Registry of Acute Coronary Syndromes). Am J Cardiol, 2012; 109: 779-786.
16. Jackson EA, Moscucci M, Smith DE et al. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J, 2011; 161: 106-112.
17. Jackson EA, Moscucci M, Smith DE et al. The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Am Heart J, 2011; 161: 106-112.
18. Sadowski M, Ga̧sior M, Gierlotka M et al. Gender-related differences in mortality after ST-segment elevation myocardial infarction: a large multicentre national registry. EuroIntervention, 2011; 6: 1068-1072.
19. Szygula-Jurkiewicz B, Wilczek K, Zembala M et al. Obserwacja 6-miesiȩczna i czynniki ryzyka zgonu u 458 chorych z ostrymi zespołami wieńcowymi bez przetrwałego uniesienia odcinka ST poddanych wczesnej strategii inwazyjnej. Pol Arch Med Wewn, 2004; 112: 1459-1466.
20. Mumma BE, Baumann BM, Diercks DB et al. Sex bias in cardiovascular testing: the contribution of patient preference. Ann Emerg Med, 2011; 57: 551-560.
21. Ferrari R, Abergel H, Ford I et al. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol, 2013; 167: 2938-2943.
22. Salomaa V, Pääkkönen R, Hämäläinen H et al. Use of secondary preventive medications after the first attack of acute coronary syndrome. Eur J Cardiovasc Prev Rehabil, 2007; 14: 386-391.
23. Tjia J, Briesacher B, Xie D et al. Disparities in combination drug therapy use in older adults with coronary heart disease: a cross-sectional time-series in a nationally representative US sample. Drugs Aging, 2010; 27: 149-158.
24. Jankowski P, Kawecka-Jaszcz K, Paja̧k A et al. Cracovian Program for Secondary Prevention of Ischemic Heart Disease. Secondary prevention of ischemic heart disease after discharge in 1997-1998 and 1999-2000. Przegl Lek, 2003; 60: 1424-1426.
25. Jankowski P, Kawecka-Jaszcz K, Paja̧k A et al. Secondary prevention of coronary artery disease in hospital practice over the decade 1996-2006. Results of Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of EuroASPIRE II and EuroASPIRE III surveys. Kardiol Pol, 2009; 67: 970-977.
26. Paja̧k A, Jankowski P, Kawecka-Jaszcz K et al. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys. Kardiol Pol, 2009; 67: 1353-1359.
27. Kotseva K, Wood D, De Backer GD et al. (The EUROASPIRE Study Group). EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil, 2009; 16: 121-137.
28. De Backer G, Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil, 2003; 10: S1-S10.
29. Puymirat E, Simon T, Steg PG et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA, 2012; 308: 998-1006.
30. Arslanian-Engoren C, Patel A et al. Symptoms of men and women presenting with acute coronary syndromes. Am J Cardiol, 2006; 98: 1177-1181.
31. Piotrowski W, Polakowska M, Koziarek J et al. Sudden cardiovascular death rate and ischaemic heart disease death rate changes during the 5-year period of 2003-2008. Kardiol Pol, 2012; 70: 1225-1234.
32. Kawecka-Jaszcz K, Pośnik-Urbańska A, Jankowski P. Rozpowszechnienie nadciśnienia tȩtniczego w zależności od płci w świetle badań epidemiologicznych w Polsce. Nad Tȩt, 2007: 11: 377-383.
33. Reibis RK, Bestehorn K, Pittrow D et al. Elevated risk profile of women in secondary prevention of coronary artery disease: a 6-year survey of 117,913 patients. J Womens Health (Larchmt), 2009; 18: 1123-1131.
34. Janion M. Myocardial infarction in women. Gender-related differences in clinical course and 6 year long term follow-up. Kardiol Pol, 1999; 51: 305-314.
35. Opotowsky AR, McWilliams JM, Cannon CP. Gender differences in aspirin use among adults with coronary heart disease in the United States. J Gen Intern Med, 2007; 22: 55-61.
36. Ben-Ami T, Gilutz H, Porath A et al. No gender difference in the clinical management and outcome of unstable angina. Isr Med Assoc J, 2005; 7: 228-232.
37. Elkoustaf RA, Mamkin I, Mather JF et al. Comparison of results of percutaneous coronary intervention for non-ST-elevation acute myocardial infarction or unstable angina pectoris in men versus women. Am J Cardiol, 2006; 98: 182-186.
38. Dallongevillle J, De Bacquer D, Heidrich J et al. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart, 2010; 96: 1744-1749.
39. Kawecka-Jaszcz K, Jankowski P, Paja̧k A et al. Wtórna prewencja choroby niedokrwiennej serca u kobiet. Krakowski Program Wtórnej Prewencji Choroby Niedokrwiennej Serca. Folia Cardiol, 2001; 8: D61-D67.
40. Starczewska ME, Pietrasik A, Główczyńska R. Prewencja chorób układu sercowo-naczyniowego w podstawowej opiece zdrowotnej: punkt widzenia lekarza domowego. Przew Lek, 2005; 6: 40-46.
41. Jankowski P. Czy jakość opieki medycznej nad osobami z niewydolnościa̧ serca można poprawić? Kardiol Pol, 2012; 70: 1009.
42. Śliż D, Filipiak KJ, Naruszewicz M et al. Standards of statin usage in Poland in high-risk patients: 3ST-POL study results. Kardiol Pol, 2013; 71: 253-259.
43. Kawecka-Jaszcz K, Jankowski P, Paja̧k A. Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. Int J Cardiol, 2003; 91: 15-23.